Exelixis (EXEL) Current Deferred Revenue (2016 - 2023)
Historic Current Deferred Revenue for Exelixis (EXEL) over the last 14 years, with Q2 2023 value amounting to $13.5 million.
- Exelixis' Current Deferred Revenue fell 813.07% to $13.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $13.5 million, marking a year-over-year decrease of 813.07%. This contributed to the annual value of $14.1 million for FY2022, which is 1500.03% down from last year.
- Exelixis' Current Deferred Revenue amounted to $13.5 million in Q2 2023, which was down 813.07% from $13.4 million recorded in Q1 2023.
- Exelixis' 5-year Current Deferred Revenue high stood at $19.0 million for Q2 2021, and its period low was $321000.0 during Q2 2019.
- In the last 5 years, Exelixis' Current Deferred Revenue had a median value of $13.8 million in 2022 and averaged $12.1 million.
- The largest annual percentage gain for Exelixis' Current Deferred Revenue in the last 5 years was 497788.16% (2020), contrasted with its biggest fall of 9639.37% (2020).
- Exelixis' Current Deferred Revenue (Quarter) stood at $8.2 million in 2019, then grew by 29.27% to $10.6 million in 2020, then skyrocketed by 56.16% to $16.6 million in 2021, then dropped by 15.0% to $14.1 million in 2022, then decreased by 3.87% to $13.5 million in 2023.
- Its Current Deferred Revenue was $13.5 million in Q2 2023, compared to $13.4 million in Q1 2023 and $14.1 million in Q4 2022.